These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lui SF; Chung WW; Leung CB; Chan K; Lai KN Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870 [TBL] [Abstract][Full Text] [Related]
44. Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Navarro JF; Mora C; Macía M; García J Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762 [TBL] [Abstract][Full Text] [Related]
45. Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients. Kang DH; Yoon KI; Han DS Nephrol Dial Transplant; 1998 Nov; 13(11):2877-83. PubMed ID: 9829494 [TBL] [Abstract][Full Text] [Related]
50. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461 [TBL] [Abstract][Full Text] [Related]
51. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients. Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161 [TBL] [Abstract][Full Text] [Related]
52. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity. Li Y; Chen H; Tan J; Wang X; Liang H; Sun X Eur J Clin Invest; 1998 Dec; 28(12):1050-4. PubMed ID: 9893018 [TBL] [Abstract][Full Text] [Related]
53. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Jacobson SH; Egberg N; Hylander B; Lundahl J Am J Nephrol; 2002; 22(1):42-7. PubMed ID: 11919402 [TBL] [Abstract][Full Text] [Related]
55. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657 [TBL] [Abstract][Full Text] [Related]
56. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo). Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893 [TBL] [Abstract][Full Text] [Related]
57. Markers of endothelial activation in preeclampsia. Prochazka M; Procházková J; Lubušký M; Pilka R; Úlehlová J; Michalec I; Polák P; Kacerovský M; Slavik L Clin Lab; 2015; 61(1-2):39-46. PubMed ID: 25807636 [TBL] [Abstract][Full Text] [Related]
58. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. Lip GY; Blann AD; Jones AF; Beevers DG Am Heart J; 1997 Oct; 134(4):764-71. PubMed ID: 9351746 [TBL] [Abstract][Full Text] [Related]